RT Journal Article
SR Electronic
T1 Clinical outcomes of prexasertib monotherapy in recurrent <em>BRCA</em> wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e000516
DO 10.1136/jitc-2019-000516
VO 8
IS 2
A1 Lampert, Erika J
A1 Cimino-Mathews, Ashley
A1 Lee, Joo Sang
A1 Nair, Jayakumar
A1 Lee, Min-Jung
A1 Yuno, Akira
A1 An, Daniel
A1 Trepel, Jane B
A1 Ruppin, Eytan
A1 Lee, Jung-Min
YR 2020
UL http://jitc.bmj.com/content/8/2/e000516.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.